First Trust Advisors LP Veracyte, Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Veracyte, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 79,767 shares of VCYT stock, worth $2.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,767

Previous 18,622 328.35%

Holding current value

$2.93 Million

Previous $403,000 573.45%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$21.0 - $35.25 $1.28 Million - $2.16 Million	61,145 Added 328.35%	79,767 $2.71 Million
Q2 2024 Aug 13, 2024	SELL	$18.86 - $23.55 $1.18 Million - $1.48 Million	-62,730 Reduced 77.11%	18,622 $403,000
Q1 2024 May 13, 2024	SELL	$21.0 - $29.1 $152,292 - $211,033	-7,252 Reduced 8.18%	81,352 $1.8 Million
Q4 2023 Feb 13, 2024	SELL	$19.72 - $28.68 $276,711 - $402,437	-14,032 Reduced 13.67%	88,604 $2.44 Million
Q3 2023 Nov 13, 2023	SELL	$22.33 - $29.92 $770,005 - $1.03 Million	-34,483 Reduced 25.15%	102,636 $2.29 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $2.87 Million - $3.7 Million	137,119 New	137,119 $3.49 Million
Q4 2022 Feb 09, 2023	BUY	$15.31 - $29.94 $577,921 - $1.13 Million	37,748 Added 130.66%	66,639 $1.58 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $269,938 - $454,239	16,281 Added 129.11%	28,891 $480,000
Q2 2022 Aug 12, 2022	SELL	$15.45 - $29.52 $345,724 - $660,569	-22,377 Reduced 63.96%	12,610 $251,000
Q1 2022 May 13, 2022	BUY	$21.94 - $42.51 $7,876 - $15,261	359 Added 1.04%	34,987 $965,000
Q4 2021 Feb 08, 2022	BUY	$36.09 - $53.79 $1.25 Million - $1.86 Million	34,628 New	34,628 $1.43 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $1.17 Million - $1.74 Million	-32,826 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $989,517 - $1.7 Million	-30,040 Reduced 47.78%	32,826 $1.31 Million
Q1 2021 May 14, 2021	BUY	$44.47 - $81.38 $889,933 - $1.63 Million	20,012 Added 46.7%	62,866 $3.38 Million
Q4 2020 Feb 02, 2021	BUY	$32.49 - $61.88 $822,581 - $1.57 Million	25,318 Added 144.38%	42,854 $2.1 Million
Q3 2020 Nov 05, 2020	SELL	$26.73 - $35.67 $1.11 Million - $1.48 Million	-41,480 Reduced 70.29%	17,536 $570,000
Q2 2020 Jul 22, 2020	SELL	$19.49 - $28.11 $52,233 - $75,334	-2,680 Reduced 4.34%	59,016 $1.53 Million
Q1 2020 May 06, 2020	BUY	$16.13 - $30.17 $779,885 - $1.46 Million	48,350 Added 362.28%	61,696 $1.5 Million
Q4 2019 Feb 03, 2020	BUY	$20.78 - $29.99 $277,329 - $400,246	13,346 New	13,346 $373,000

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.63B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Veracyte, Inc. Transaction History